FDA OKs Philips Breast Cancer Risk Assessment Software; Phil Meyer Comments

PhilipsLogoThe Food and Drug Administration has approved a Royal Philips-built software application designed to evaluate breast density in women who undergo digital mammograms.

Philips’ Spectral Breast Density Measurement Application is intended to work with Philip’s MicroDose SI technology that is used for breast cancer screening, Philips said Thursday.

According to the company, the software works to compare the amounts of adipose and grandular tissues in the breast, then automatically correlate the resulting score to the BI-RADS breast density classification system.

Phil Meyer, Philips’ general manager and vice president for diagnostic X-ray and women’s health in North America, said the platform is built to help clinicians identify treatment methods for women with breast cancer.

The company designed the imaging app to meet state laws requiring health care providers to provide women with breast density information in mammogram reports.

Filed in: Healthcare IT, News Tags: , , , , , ,

You might like:

JJ van Dongen: Philips Aims to Tap Kenya’s R&D Ecosystem Through New Innovation Center JJ van Dongen: Philips Aims to Tap Kenya’s R&D Ecosystem Through New Innovation Center
James Rawson: Georgia Medical Center Implements Philips Medical Imaging Tool James Rawson: Georgia Medical Center Implements Philips Medical Imaging Tool
Philips to Support Telemonitoring Clinical Program; Brian Rosenfeld Comments Philips to Support Telemonitoring Clinical Program; Brian Rosenfeld Comments
IBM Launches Application Development Cloud Servers; Doug Balog Comments IBM Launches Application Development Cloud Servers; Doug Balog Comments

Leave a Reply

Submit Comment

© 2014 ExecutiveBiz. All rights reserved.

A Digest of ExecutiveBiz's Daily Coverage of GovCon

  • Executive Analysis
  • Technology & Innovation
  • Business

Sign up for the ExecutiveBiz Digest